Yingying Shi

9PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 09, 2026
Apatinib in combination with docetaxel and S-1 chemotherapy as first-line treatment for metastatic gastric cancer.

Ling Xia, Yu Gao, Lei Yang

|Dec 09, 2022
HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy.

Bo-Lin Xiao, Xiao-Le Wang, Hou-Fu Xia

|Aug 05, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Feng Wang, Ming-Ming He, Jian Xiao

|Aug 01, 2022
MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin/Src/FAK signaling.

Haibin Ou, Lili Wang, Ziyao Xi

|May 05, 2022
A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer.

Shuang Dong, Binlei Liu, Sheng Hu

|Sep 07, 2021
Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca2+]m-PDP1-PDH-histone acetylation retrograde signaling.

Yingying Shi, You Wang, Huangang Jiang

Pageof 2

Frequent Collaborators

2 joint publications

Yunfeng Zhou

1 joint publications

Feng Wang

1 joint publications

Ming-Ming He

1 joint publications

Jian Xiao